NCT06878924Not yet recruiting
Safety and Efficacy of Pulmonary Vein Isolation Using Pulsed-field Ablation (PFA) Combined with Either PFA-based Left Atrial Posterior Wall Isolation or Vein of Marshall Ethanol Ablation in Patients with Persistent Atrial Fibrillation
Source: ClinicalTrials.gov · Last updated 17 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is designed to directly compare the safety and efficacy of PFA-based PVI+PWI vs PFA-based PVI+ VoM alcohol ablation in patients with Persistent AF.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 162 (estimated)
- First submitted
- 5 Mar 2025
- Start date
- May 2025
- Primary completion date
- May 2027
- Lead sponsor
- Texas Cardiac Arrhythmia Research Foundation
- Diseases
- Atrial fibrillation
- NCT number
- NCT06878924
What you commit to
- Study type: Observational
- Planned participants: 162
- From May 2025 to the primary completion date, May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- • Previous PWI or VoM ablation procedure
- Left ventricular ejection fraction \<40%
- Left atrial thrombus
- Myocardial infarction within last 60 days
- Cardiac surgery in the last 6 months
- Advanced renal failure
- Life expectancy \<1 year
- Pregnant women
- Unable or unwilling to provide informed consent
Who the study is looking for
- Symptomatic persistent AF; 1st or redo ablation with PVI-only in the earlier procedure
- Willing to provide informed consent
- Age: 18-85 years
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.